Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability
暂无分享,去创建一个
C Binquet | A. Mégarbané | A. Toutain | N. Philip | G. Jondeau | P. Jouk | D. Lacombe | L. Pasquier | E. Colin | J. Thevenon | G. Collod-Béroud | S. Lyonnet | L. Faivre | C. Baumann | C. Thauvin-Robinet | C. Boileau | Pierre Vabres | C. Goizet | B. Aral | V. Cormier-Daire | P. Callier | J. Amiel | C. Binquet | F. Huet | A. Jacquette | S. Odent | C. Coubes | M. Doco‐Fenzy | D. Heron | H. Journel | C. Francannet | Y. Dulac | A. Goldenberg | M. Delrue | M. Addor | G. Plessis | N. Marle | B. Leheup | Y. Sznajer | F. Mugneret | D. Martin‐Coignard | P. Sarda | C Boileau | V. Carmignac | V Cormier-Daire | S Lyonnet | J Amiel | D Heron | P S Jouk | G Jondeau | S. Julia | A. Mosca-Boidron | M. Payet | C. Ragon | N Philip | L Faivre | G Collod-Beroud | P Khau Van Kien | P Callier | B Aral | N Hanna | S Lambert | H Dindy | C Ragon | M Payet | V Carmignac | M A Delrue | C Goizet | T Busa | Y Dulac | I Missotte | Y Sznajer | A Toutain | C Francannet | A Megarbane | S Julia | T Edouard | P Sarda | B Gilbert | A Jacquette | P Collignon | D Lacombe | F Morice-Picard | V Cusin | M Willems | E Sarrazin | K Amarof | C Coubes | M C Addor | H Journel | E Colin | C Baumann | B Leheup | D Martin-Coignard | M Doco-Fenzy | A Goldenberg | G Plessis | J Thevenon | L Pasquier | S Odent | P Vabres | F Huet | N Marle | A L Mosca-Boidron | F Mugneret | S Gauthier | C Thauvin-Robinet | S. Gauthier | N. Hanna | E. Sarrazin | P. Khau Van Kien | M. Willems | B. Gilbert | V. Cusin | T. Edouard | P. Collignon | T. Busa | I. Missotte | F. Morice-Picard | S. Lambert | H. Dindy | K. Amarof
[1] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[2] S. Knuutila,et al. 19p13.3 Aberrations Are Associated with Dysmorphic Features and Deviant Psychomotor Development , 2010, Cytogenetic and Genome Research.
[3] H. Dietz,et al. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome , 1996, Nature Genetics.
[4] R. Kosaki,et al. Molecular pathology of Shprintzen–Goldberg syndrome , 2006, American journal of medical genetics. Part A.
[5] C. Béroud,et al. A new locus‐specific database (LSDB) for mutations in the TGFBR2 gene: UMD‐TGFBR2 , 2008, Human mutation.
[6] R E Pyeritz,et al. Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.
[7] D. Milewicz,et al. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.
[8] J. Fryns,et al. X-linked mental retardation with Marfanoid habitus: a changing phenotype with age? , 1991, Genetic counseling.
[9] Gabor Matyas,et al. Update of the UMD‐FBN1 mutation database and creation of an FBN1 polymorphism database , 2003, Human mutation.
[10] C. Magri,et al. De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia. , 2011, European journal of medical genetics.
[11] M. Williams,et al. Aortic root dilation in apparent Lujan-Fryns syndrome. , 1999, American journal of medical genetics.
[12] L. Tavazzi,et al. Identification of sixty‐two novel and twelve known FBN1 mutations in eighty‐one unrelated probands with Marfan syndrome and other fibrillinopathies , 2005, Human mutation.
[13] Andrew Menzies,et al. Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. , 2007, American journal of human genetics.
[14] G. Pals,et al. Compound-heterozygous Marfan syndrome. , 2009, European journal of medical genetics.
[15] Sjzhong Zhang,et al. 5p;12q translocation with manifestations of cri du chat syndrome and Marfanoid arachnodactyly , 1990, Clinical genetics.
[16] J. Opitz,et al. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome , 2007, Nature Genetics.
[17] B. Chevallier,et al. Syndrome de Marfan : critères diagnostiques et apport de la biologie moléculaire , 2008 .
[18] H. Lubs,et al. A form of X-linked mental retardation with marfanoid habitus. , 1984, American journal of medical genetics.
[19] J. Mosser,et al. Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation. , 2011, European journal of medical genetics.
[20] A. De Paepe,et al. Cytogenetic and array‐CGH characterization of a 6q27 deletion in a patient with developmental delay and features of Ehlers–Danlos syndrome , 2010, American journal of medical genetics. Part A.
[21] J. Vermeesch,et al. Mosaicism for duplication 12q (12q13→12q21.2) accompanied by a pericentric inversion in a dysmorphic female infant , 2002, Journal of medical genetics.
[22] J. Harvey,et al. Application of dHPLC for mutation detection of the fibrillin-1 gene for the diagnosis of Marfan syndrome in a National Health Service Laboratory. , 2007, Genetic testing.
[23] E. Conti,et al. Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. , 2005, Current opinion in cell biology.
[24] P. Robinson,et al. Shprintzen–Goldberg syndrome: Fourteen new patients and a clinical analysis , 2005, American journal of medical genetics. Part A.
[25] Yu Wang,et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures , 2008, Nature Genetics.
[26] Marjo-Riitta Järvelin,et al. Temporal changes in incidence and prevalence of intellectual disability between two birth cohorts in Northern Finland. , 2003, American journal of mental retardation : AJMR.
[27] F. López-Muñoz,et al. Psychopathology in the Lujan–Fryns syndrome: Report of two patients and review , 2006, American journal of medical genetics. Part A.
[28] F. Flinter,et al. Terminal deletion of chromosome 5p in a patient with phenotypical features of Lujan–Fryns syndrome , 2003, American journal of medical genetics. Part A.
[29] A. Child,et al. Erratum: Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome , 2001, Human mutation.
[30] M. V. van Steensel,et al. Shprintzen‐Goldberg syndrome associated with a novel missense mutation in TGFBR2 , 2008, Experimental dermatology.
[31] J. Gécz,et al. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation , 2007, Nature Genetics.
[32] Laurence Faivre,et al. The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.
[33] R. Shprintzen,et al. Shprintzen-Goldberg syndrome: a clinical analysis. , 1998, American journal of medical genetics.
[34] M. Stratton,et al. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene , 2007, Journal of Medical Genetics.
[35] P. Elliott,et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus , 2011, Nature.
[36] Christophe Béroud,et al. UMD‐predictor, a new prediction tool for nucleotide substitution pathogenicity—application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2 , 2009, Human mutation.
[37] G. Neri,et al. A girl with the Lujan-Fryns syndrome. , 1991, American journal of medical genetics.
[38] B. D. de Vries,et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.
[39] Glen Brice,et al. The importance of mutation detection in Marfan syndrome and Marfan‐related disorders: report of 193 FBN1 mutations , 2007, Human mutation.
[40] E. Haan,et al. FBN1, TGFBR1, and the Marfan‐craniosynostosis/mental retardation disorders revisited , 2006, American journal of medical genetics. Part A.
[41] H. Zoghbi,et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.
[42] D. Creamer,et al. A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine: comment , 2012, Clinical and experimental dermatology.
[43] E. Arbustini,et al. The new Ghent criteria for Marfan syndrome: what do they change? , 2012, Clinical genetics.
[44] R. Deschenes,et al. DHHC9 and GCP16 Constitute a Human Protein Fatty Acyltransferase with Specificity for H- and N-Ras* , 2005, Journal of Biological Chemistry.
[45] R. Tervo,et al. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.
[46] E. Arbustini,et al. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: Further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion , 2009, American journal of medical genetics. Part A.
[47] Ton Feuth,et al. Diagnostic genome profiling in mental retardation. , 2005, American journal of human genetics.
[48] M Claustres,et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.
[49] A. Mégarbané,et al. Severe mental retardation with marfanoid habitus in a young Lebanese male. A diagnostic challenge. , 1997, Genetic counseling.
[50] C. Junien,et al. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype‐phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys‐Dietz syndrome and related disorders , 2008, Human mutation.
[51] E. Arbustini,et al. Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands , 2008, Journal of Medical Genetics.
[52] M. Meisterernst,et al. The Mediator of RNA polymerase II , 2005, Chromosoma.
[53] Bruce Bennetts,et al. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy , 2004, Human mutation.
[54] K. Gervin,et al. Rapid and efficient FBN1 mutation detection using automated sample preparation and direct sequencing as the primary strategy. , 2006, Genetic testing.
[55] M. Holder,et al. Delineation of 15q13.3 microdeletions , 2010, Clinical genetics.
[56] M. Tzetis,et al. De novo interstitial duplication of the 15q11.2‐q14 PWS/AS region of maternal origin: Clinical description, array CGH analysis, and review of the literature , 2010, American journal of medical genetics. Part A.
[57] J. Fryns,et al. X-linked mental retardation with marfanoid habitus. , 1987, American journal of medical genetics.
[58] P. Stankiewicz,et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12 , 2010, European Journal of Human Genetics.
[59] P. Robinson,et al. Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 Mutations , 2009, Pediatrics.
[60] B. Chevallier,et al. [Marfan syndrome: diagnostic criteria and molecular biology contribution]. , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[61] Jean-Pierre Fryns,et al. Lujan-Fryns syndrome (mental retardation, X-linked, marfanoid habitus) , 2006, Orphanet Journal of Rare Diseases.
[62] Sung-Kook Hong,et al. The zebrafish kohtalo/trap230 gene is required for the development of the brain, neural crest, and pronephric kidney. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[64] T. Wassink,et al. Polymorphism analysis of HOPA: A candidate gene for schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[65] V. Dulieu,et al. De novo 15q21.1q21.2 deletion identified through FBN1 MLPA and refined by 244K array-CGH in a female teenager with incomplete Marfan syndrome. , 2010, European journal of medical genetics.
[66] E. Arbustini,et al. The FBN1 (R2726W) mutation is not fully penetrant , 2004, Annals of human genetics.